Springer Nature
Browse
40035_2021_235_MOESM1_ESM.pdf (249.76 kB)

Additional file 1 of Pharmacological inhibition of asparaginyl endopeptidase by δ-secretase inhibitor 11 mitigates Alzheimer’s disease-related pathologies in a senescence-accelerated mouse model

Download (249.76 kB)
journal contribution
posted on 2021-04-01, 11:22 authored by Ju Wang, Hui-Jie Hu, Zi-Kai Liu, Jing-Jing Liu, Shan-Shan Wang, Qing Cheng, Hong-Zhuan Chen, Mingke Song
Additional file 1: Figure S1. Effect of δ-secretase inhibitor 11 on body weight and AEP activity.

Funding

National Natural Science Foundation of China Innovative Research Team of High-level Local Universities in Shanghai, China

History

Usage metrics

    Translational Neurodegeneration

    Categories

    Keywords

    Alzheimer’s diseaseAsparaginyl endopeptidaseLegumainSAMP8 mouseδ-Secretase inhibitor 11Therapeutic target

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC